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Abstract
Objective:  To  verify  genetic  determinants  associated  with  stroke  in  children  with  sickle  cell
disease (SCD).
Methods:  Prospective  cohort  with  110  children  submitted  to  neonatal  screening  by  the  Neonatal
Screening Program,  between  1998  and  2007,  with  SCD  diagnosis,  followed  at  a  regional  reference
public service  for  hemoglobinopathies.  The  analyzed  variables  were  type  of  hemoglobinopathy,
gender, coexistence  with  alpha  thalassemia  (-thal),  haplotypes  of  the  beta  globin  chain  cluster,
and stroke.  The  ﬁnal  analysis  was  conducted  with  66  children  with  sickle  cell  anemia  (SCA),
®using the  chi-squared  test  in  the  program  SPSS version  14.0.
Results:  Among  children  with  SCD,  60%  had  SCA.  The  prevalence  of  coexistence  with  -thal
was 30.3%  and  the  Bantu  haplotype  (CAR)  was  identiﬁed  in  89.2%.  The  incidence  of  stroke
 Please cite this article as: Rodrigues DO, Ribeiro LC, Sudário LC, Teixeira MT, Martins ML, Pittella AM, et al. Genetic determinants and
troke in children with sickle cell disease. J Pediatr (Rio J). 2016;92:602--8.
 Study carried out at Fundac¸ão Hemominas and Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora, MG, Brazil.
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was  signiﬁcantly  higher  in  those  with  SCA  (27.3%  vs.  2.3%;  p  =  0.001)  and  males  (24.1%  vs.  9.6%;
p =  0.044).  The  presence  of  -thal  (p  =  0.196),  the  CAR  haplotype  (p  =  0.543),  and  socioeconomic
factors were  not  statistically  signiﬁcant  in  association  with  the  occurrence  of  stroke.
Conclusion:  There  is  a  high  incidence  of  stroke  in  male  children  and  in  children  with  SCA.
Coexistence  with  -thal  and  haplotypes  of  the  beta  globin  chain  cluster  did  not  show  any  sig-
niﬁcant association  with  stroke.  The  heterogeneity  between  previously  evaluated  populations,
the non-reproducibility  between  studies,  and  the  need  to  identify  factors  associated  with  stroke
in patients  with  SCA  indicate  the  necessity  of  conducting  further  research  to  demonstrate  the
relevance  of  genetic  factors  in  stroke  related  to  SCD.
© 2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
PALAVRAS-CHAVE
Anemia  falciforme;
Acidente  vascular
cerebral;
Marcadores
genéticos;
Alfa  talassemia;
Haplótipos
Determinantes  genéticos  e  Acidente  Vascular  Encefálico  em  crianc¸as com  doenc¸a
falciforme
Resumo
Objetivo:  Veriﬁcar  fatores  genéticos  associados  ao  acidente  vascular  encefálico  (AVE)  em
crianc¸as com  Doenc¸a  Falciforme  (DF).
Métodos:  Coorte  prospectiva  de  110  crianc¸as  submetidas  à  triagem  neonatal  pelo  Programa
de Triagem  Neonatal,  entre  1998-2007  com  o  diagnóstico  de  DF,  atendidas  em  servic¸o
público regional  de  referência  em  hemoglobinopatias.  As  variáveis  analisadas  foram:  tipo  de
hemoglobinopatia,  sexo,  coexistência  da  alfa  Talassemia  (-Tal),  haplótipos  do  cluster  da  cadeia
beta globina  e  AVE.  A  análise  estatística  ﬁnal  foi  realizada  com  66  crianc¸as  com  Anemia  Falci-
forme, por  meio  do  teste  do  Qui-quadrado  no  programa  SPSS® 14.0.
Resultados:  Entre  as  crianc¸as  com  DF,  60%  eram  portadoras  de  Anemia  Falciforme.  A  prevalência
da coexistência  com  a  -Tal  foi  de  30,3%  e  o  haplótipo  Bantu  (CAR)  foi  identiﬁcado  em  89,2%.
A incidência  de  AVE  foi  signiﬁcativamente  maior  nas  crianc¸as  com  AF  (27,3%  versus  2,3%;  p  =
0,001) e  no  sexo  masculino  (24,1%  versus  9,6%;  p  =  0,044).  A  presenc¸a  da  -Tal  (p  =  0,196),  do
haplótipo  CAR  (p  =  0,543)  e  fatores  socioeconômicos  não  foram  signiﬁcantemente  associadas  à
ocorrência  de  AVE.
Conclusão:  O  AVE  apresenta  alta  incidência  em  crianc¸as  com  AF  e  em  crianc¸as  do  sexo  mas-
culino. Coexistência  de  -Tal  ou  de  haplótipos  do  cluster  da  beta  globina  não  apresentaram
associac¸ão signiﬁcante  com  AVE.  A  heterogeneticidade  entre  as  populac¸ões  previamente  avali-
adas e  a  não  reprodutibilidade  entre  estudos  indicam  a  necessidade  de  realizac¸ão  de  novas
pesquisas  para  veriﬁcar  o  papel  desses  fatores  genéticos  no  AVE  em  crianc¸as  com  DF.
© 2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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Sickle  cell  disease  (SCD)  is  the  most  common  mono-
genic  hereditary  disease  in  Brazil,  occurring  predominantly
among  those  of  African  descent.  The  term  SCD  includes
sickle  cell  anemia  (SCA)  and  pathological  conditions  in
which  the  hemoglobin  S  gene  is  associated  with  other
hemoglobinopathies,  such  as  SC,  S/beta0 and  S/beta+ tha-
lassemia  (S/b),  and  SD  Punjab,  among  others.1 SCA,  caused
by  a  single  mutation  in  the  -globin  gene,  produces  a  diver-
sity  of  phenotypic  expressions  in  affected  patients.2,3 SCA
is  the  most  severe  form  of  SCD  presentation;  for  the  dis-
ease  to  manifest,  homozygosity  of  S alleles  in  the  gene
responsible  for  the  synthesis  of    chain  of  hemoglobin
is  required,  determining  the  formation  of  hemoglobin
S  (HbSS).
HbSS,  under  conditions  such  as  low  oxygenation,
metabolic  acidosis,  or  dehydration,  becomes  polymerized,
d
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wrreversibly  changing  the  structure  of  erythrocyte,  thus
etermining  inefﬁcient  oxygenation,  endothelial  inﬂamma-
ory  reaction,  and  the  entire  complex  physiopathology  of
he  disease.3,4 The  polymerization  process  leads  to  vascu-
ar  occlusion,  which  can  trigger  painful  crises,  stroke,  acute
hest  syndrome,  splenic  sequestration,  and  priapism,  among
ther  manifestations.
In  Brazil,  studies  have  shown  that  700--1000  chil-
ren/year  are  born  with  SCD,1,4--6 making  this  disease  a
ublic  health  problem.  The  state  of  Minas  Gerais  (MG)  is  a
ioneer  in  Brazil  in  the  early  diagnosis  of  SCD,  with  the  intro-
uction  of  the  Neonatal  Screening  Program  of  the  State  of
inas  Gerais  (Programa  de  Triagem  Neonatal  do  Estado  de
inas  Gerais  [PETN-MG])  in  March  1998.  PETN-MG  is  coor-
inated  by  the  Center  for  Action  and  Research  in  Support
iagnostics  (Núcleo  de  Ac¸ões  e  Pesquisa  em  Apoio  Diag-
óstico  [NUPAD])  of  Universidade  Federal  de  Minas  Gerais,
hich  refers  newborns  diagnosed  with  SCD  to  be  followed  at
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undac¸ão Hemominas.  From  1998  to  2007,  2,549,097  chil-
ren  were  screened  in  MG,  of  whom  188,916  were  born  in
he  39  municipalities  included  in  the  regional  reference  pub-
ic  services  for  hemoglobinopathies  --  where  this  study  was
arried  out  --  which  represents  7.41%  of  the  total  number
n  the  state.  The  PETN-MG  coverage  in  2007  was  88.57%,
hich  is  higher  than  the  national  average  of  9.65%  (Ministry
f  Health,  National  Neonatal  Screening  Program,  2009).
Stroke  is  one  of  the  most  severe  complications  of  SCD  and
s  responsible  for  20%  of  mortality  among  these  patients.2,7
ccording  to  the  Cooperative  Study  Group  in  SCD,  the  over-
ll  incidence  of  the  ﬁrst  stroke  was  0.08  acute  events/
00  patients/year  in  children  under  2  years;  0.75  in  patients
etween  2  and  5  years  of  age;  0.55  between  6  and  9  years
f  age;  0.30  between  10  and  19  years;  and  0.45  between  20
nd  29  years.  Among  the  SCD,  the  incidence  of  stroke  is  0.61
or  patients  with  Hb  SS,  0.17  for  Hb  SC,  and  0.11  for  S/beta
halassemia.1,2,7
Currently,  the  use  of  transcranial  Doppler  (TCD),  a  non-
nvasive  ultrasound  method  that  measures  the  velocity  and
ow  alteration  of  intracerebral  vessels,  is  considered  a  sen-
itive  tool  for  the  identiﬁcation  of  ischemic  stroke  risk.1
The  association  between  stroke,  coexistence  of  alpha-
halassemia(del ˛-3,7) (-thal),  and  cluster  haplotypes  of  the
eta  globin  S is  variable  in  the  literature.  Studies  pub-
ished  with  data  from  Rio  de  Janeiro,4,8 MG,9 and  Sao  Paulo4,9
how  controversial  results.  Some  studies  have  reported
hat  the  coexistence  of  -thal  would  help  reduce  the  risk
f  stroke,9--12 while  others  did  not  demonstrate  such  an
ssociation.6,13
These  studies  have  identiﬁed  characteristics  regarding
he  frequency  of  different  haplotypes,  with  a  high  preva-
ence  of  individuals  homozygous  for  the  Central  African
epublic  (CAR)  and  Benin  haplotypes,  reﬂecting  the  origin
f  the  ﬂow  of  African  slaves  who  were  received  at  the  time
f  colonial  Brazil.4,9,14 In  Jamaica  and  the  United  States,
he  Benin  haplotype  is  much  more  frequent  than  the  CAR
aplotype.  Such  genetic  differences  make  generalizations
f  results  between  regions  inappropriate.
The  aim  of  this  study  was  to  investigate  genetic  factors
ssociated  with  risk  of  stroke  in  children  with  SCD.
ethod
etween  1998  and  2007,  188,916  children  born  in  the  region
f  Zona  da  Mata  Mineira  and  Vertentes  underwent  neonatal
creening  for  SCD  through  the  PETN-MG.  During  this  period,
35  children  with  SCD  were  referred  to  a  reference  pub-
ic  institution  for  hemoglobinopathies.  Of  this  total,  nine
ied  before  the  start  of  the  project,  six  children  with  SCD
ypes  SD  and  S  were  excluded,  and  ten  cases  were  lost
o  follow-up,  thus  totaling  110  children  who  comprised  the
tudy  population.
Conﬁrmatory  diagnosis  of  SCD  was  carried  out  by
emoglobin  electrophoresis  on  alkaline  pH  after  6  and  12
onths  of  age,  measurement  of  hemoglobin  A2  by  chro-
atography,  radial  immunodiffusion  for  fetal  hemoglobin
HbF),  and  molecular  analysis  of  codon  6  of  beta  globin.
hildren  with  SCA,  SC,  S/b0,  and  S/b+ were  considered  for
nclusion  in  the  study.
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Clinical  and  laboratory  data  were  extracted  from  medical
ecords,  in  the  period  between  the  date  of  enrollment  at  the
nstitution  until  December  31,  2013  (end  of  cohort  follow-
p),  allowing  a  follow-up  of  at  least  ﬁve  years  of  the  study
ubjects.  Socioeconomic  characteristics  were  obtained  by
pplying  the  questionnaire  from  the  Anisio  Teixeira  National
nstitute  of  Educational  Studies  and  Research  (Instituto
acional  de  Estudos  e  Pesquisas  Educacionais  Anísio  Teixeira
INEP]),  plus  questions  about  the  caregiver’s  level  of  school-
ng  and  family  income.  The  study  to  identify  the  haplotypes
nd  screening  for  -thal  was  initiated  in  November  2010,
fter  approval  by  the  funding  agency  through  the  Research
rogram  for  SUS  (health  system  in  Brazil)  --  PPSUS/Fundac¸ão
e  Amparo  à  Pesquisa  do  Estado  de  Minas  Gerais  (Fundac¸ão
e  Amparo  à  Pesquisa  do  Estado  de  Minas  Gerais  [FAPEMIG]).
The  outcome  variable  was  the  presence  of  stroke  (yes  or
o).  The  diagnosis  of  stroke  was  attained  clinically  (ischemic
troke  or  transient  ischemic  attack)  or  through  additional
ests  such  as  transcranial  Doppler  (TCD)  and  magnetic  reso-
ance  angiography  (MRA)  of  cerebral  vessels.
The  screening  for  the  presence  of  stroke  through  TCD  has
een  offered  annually  to  all  children  being  followed  with
CD,  between  2  and  16  years  of  age,  as  recommended  by
he  Brazilian  Protocol  since  2007  in  Belo  Horizonte,  and  since
012  at  the  regional  unit  of  this  study.  The  test  is  performed
n  all  patients  with  SCD,  although  there  are  no  established
elocity  parameters  for  SCD  type  SC  and  S/beta+.1 The
ssessment  of  the  rate  of  cerebral  blood  ﬂow  in  the  great
rteries  of  the  circle  of  Willis  was  based  on  the  criteria
rom  the  Stroke  Prevention  Trial  in  Sickle  Cell  Anemia  (STOP)
tudy.1
The  TCD  results  were  stratiﬁed  according  to  the
lassiﬁcation  proposed  by  the  STOP  study,  adding  the  recom-
endation  to  include  the  mean  maximal  velocity  (MMV)  in
ne  of  the  anterior  cerebral  arteries  ≥170  cm/s  as  also  rep-
esenting  a  high  risk  of  developing  ischemic  stroke.15 The
ain  assessed  arteries  were  the  middle  cerebral  arteries
nd  their  bifurcations,  and  the  distal  internal  carotid  artery.
he  conﬁrmation  of  an  abnormal  test  (high  risk)  was  made
hrough  double  repetition,  with  an  interval  of  one  to  four
eeks.
Children  conﬁrmed  as  high-risk  for  ischemic  stroke  were
eferred  for  primary  preventive  treatment  of  the  event  with
 hypertransfusion  regimen.  At  the  time  of  the  TCD,  there
ere  no  children  undergoing  exchange  transfusion  therapy
r  being  treated  with  hydroxyurea.
Genetic  factors  considered  in  the  analysis  were:
.  Type  of  SCD  (SCA  or  another  type:  SC,  S/b0,  and  S/b+
thalassemia)  with  diagnosis  conﬁrmed  according  to  the
abovementioned  methodology;
.  Gender  (male  or  female);
.  Presence  or  absence  of  the  mutation  for  the  -thal  gene;
.  Identiﬁcation  of  the  haplotype  (CAR  or  non-CAR).
To  determine  the  deletion  mutation  for  -thal  and  hap-
otypes,  5  mL  of  whole  blood  were  collected  in  tubes  with
thylenediaminetetraacetic  acid  (EDTA)  during  routine  SCD
aboratory  monitoring.  The  extraction  and  quantitation  of
enomic  DNA  was  performed  using  the  commercial  QIAamp
NA  Blood  Mini  Kit  (QIAGEN®,  USA)  and  Invitrogen® (Invitro-
en  Corporation®,  USA),  with  restriction  enzymes  (BioLabs
605
Table  1  Haplotypes  identiﬁed  in  children  with  sickle  cell
disease.
Analysis  of  the  beta-chain  globin  Frequency  %
CAR  CAR  35  53
CAR BEN 20  30.3
CAR SEN 1  1.5
CAR ATIP  3  4.5
ATIP ATIP  1  1.5
Not performed  6  9.1
Total 66  100
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Inc®,  USA)  according  to  manufacturer’s  instructions.  The
analyses  were  performed  at  the  research  laboratory  of  the
institution.
The  identiﬁcation  of  the  haplotypes  was  performed  using
polymerase  chain  reaction  (PCR)  and  restriction  fragment
length  polymorphism  (RFLP)  analysis  according  Sutton’s16
protocol.  A  commercial  kit  Multiplex  PCR  (QIAGEN®, USA)
was  used  for  PCR  reactions  and  −3.7 mutation  and  deletion
screening.  The  identity  of  each  deletion  was  obtained  by
determining  the  size  of  the  ampliﬁed  fragment  in  each  reac-
tion.  As  any  deletion  removes  part  or  the  entire  -2  globin
gene,  its  ampliﬁcation,  together  with  the  ampliﬁcation  of
a  deletion  allele,  indicates  that  the  mutation  is  heterozy-
gous.  As  positive  control  for  successful  DNA  ampliﬁcation,
this  study  used  a  2350  bp  segment,  related  to  the  nontran-
scribed  region  3  of  the  LIS-1  gene  (platelet  factor)  located  on
chromosome  17p13.3.  Other  mutations  were  not  screened,
considering  that  in  Brazil  the  deletion  that  leads  to  -thal  is
the  type  (3.7).9
The  primer  sequences  were  veriﬁed  against  the  informa-
tion  available  at  NCBI  (National  Center  for  Biotechnology
Information)  using  the  BLAST  (Basic  Local  Alignment  Search
Tool)  (http://blast.ncbi.nlm.nih.gov/Blast.cgi)  tool.
In  addition  to  the  described  genetic  factors,  the  associa-
tion  between  fetal  Hb  and  stroke  was  assessed.  The  relative
concentrations  of  fetal  Hb  in  lysed  red  blood  cells  (RBCs)  was
determined  at  5  years  of  age  and  their  value  was  stratiﬁed
according  to  Steinberg17 as  fetal  Hb  ≥10%  or  fetal  Hb  <10%.
The  children  and  their  parents/guardians  were  previously
informed  about  the  importance  of  this  study,  and  authorized
their  participation  by  signing  an  informed  consent.
The  statistical  analysis  of  the  associations  was  carried
out  through  the  Chi-squared  test,  considering  a  signiﬁcance
level  of  5%,  using  the  program  SPSS  Statistics® 14.0  (IBM
Corporation,  Somers,  NY,  United  States).
The  study  was  approved  by  the  Research  Ethics  Commit-
tee  on  10/9/2009  under  No.  245  and  is  consistent  with  the
provisions  of  Resolution  466/12  of  the  National  Health  Coun-
cil/Ministry  of  Health  and  the  Code  of  Medical  Ethics  of  1988
(Article  122-130).
Results
Of  the  110  children,  52.7%  were  males.  The  mean  age  at  end
of  the  follow-up  was  11.2  years,  with  a  standard  deviation
of  2.84.
Of  the  study  population,  60%  were  patients  with  SCA,
33.6%  had  SC  genotype,  and  6.4%  had  S/beta  thalassemia
(two  children  S/b0 and  ﬁve  with  S/b+).  The  incidence  of  SCA
was  one  case  per  2857  live  births  and  one  case  of  SCD  type  SC
for  every  5128  live  births.  The  family  income  was  up  to  two
minimum  wages  (MW)  in  72.8%  of  cases,  and  the  mother’s
level  of  schooling,  the  primary  caregiver,  was  complete  ele-
mentary  school  in  60.9%  of  cases.
The  identiﬁcation  of  the  haplotypes  showed  the  pres-
ence  of  the  CAR  gene  in  the  majority  of  patients  (89.2%),
reﬂecting  the  origin  of  the  African-descent  population  eval-
uated  in  this  study.  The  presence  of  atypical  genes  such
as  Senegal  and  Cameroon  was  identiﬁed,  previously  only
described  in  the  Northeast  of  Brazil.  It  was  not  possible  to
deﬁne  the  haplotype  in  only  one  child.  Seven  children  (6.4%)
o
d
d
tCAR, Central African Republic; BEN, Benin; SEN, Senegal; ATYP,
atypical.
id  not  undergo  genetic  testing  due  to  refusal  or  failure  to
ttend  blood  sample  collection  within  the  stipulated  time
or  research.  Of  the  66  children  with  SCA,  89.4%  had  at  least
ne  CAR  allele  (Table  1).
The  analysis  of  the  -globin  gene  deletion  showed  an
ncidence  of  -thal  of  30.9%  of  individuals.  26.4%  of  chil-
ren  were  identiﬁed  with  deletion  of  one  gene  and  4.5%
ith  deletion  of  two  genes.  In  this  population,  no  children
ere  identiﬁed  with  deletion  of  three  genes.  In  relation  to
CA,  22.7%  of  children  had  deletion  of  one  gene  and  7.6%
ad  deletion  of  two  genes  for  -thal.
A  total  of  19  children  were  identiﬁed  with  stroke,  which
epresented  an  incidence  of  17.2%.  Of  these,  three  cases
ere  identiﬁed  through  MRI  performed  after  the  clinical
anifestation  of  stroke.  Sixteen  cases  were  identiﬁed  by
CD,  13  of  whom  showed  elevated  rates  of  cerebral  blood
ow  and  areas  of  cerebral  ischemia  identiﬁed  at  the  brain
RA.  The  increased  ﬂow  velocity  in  the  right  middle  cerebral
rtery  and  its  stenosis  were  the  most  prevalent  alterations
eight  cases).  The  incidence  of  stroke  among  children  with
CA  was  27.3%.  There  were  no  cases  of  stroke  in  children  SC
nd  S/b+. The  mean  age  at  ﬁrst  stroke  was  7.7  years,  with  a
inimum  age  of  6  months  and  maximum  of  15  years.
Table  2  describes  the  factors  associated  with  stroke.
n  the  assessed  sample,  only  one  child  with  S/beta0 tha-
assemia  had  a  stroke.  Children  with  SCA  had  a  12-fold
reater  risk  for  stroke  than  those  with  other  types  of  SCD
p  =  0.001).  The  incidence  of  stroke  among  boys  was  24.1%,
ompared  to  9.6%  among  girls  (p  =  0.044).  Other  factors
howed  no  signiﬁcant  association  with  stroke.
Children  with  SCA  are  more  susceptible  to  stroke.  For
his  reason,  this  group  was  considered  for  assessment  of
he  association  of  stroke  with  the  other  factors.  The  results
epicted  in  Table  3  show  that  only  the  variable  gender  was
igniﬁcantly  associated  with  the  outcome  (p  =  0.042).
iscussion
he  most  severe  complication  of  SCA  is  stroke,  one  of  the
eading  causes  of  death  in  both  children  and  adults.  Despite
ts  high  incidence,  causes  and  factors  that  increase  the  risk
f  stroke  are  not  completely  known.  Several  lines  of  evi-
ence  suggest  that  a  genetic  signature  could  inﬂuence  the
evelopment  of  strokes  and  that  the  combined  effect  of
hese  genes  can  affect  the  severity  of  SCD.2,6,9,15,18,19
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Table  2  Frequency  of  factors  associated  with  stroke  in  individuals  with  sickle  cell  disease.
Factors  Absolute  frequency  and
percentage  of  variables
Absolute  frequency  and  percentage
of presence  of  stroke
p-Value
n  %  n  %
Type  of  hemoglobinopathy 0.001
SCA  66  60  18  27.3
S/beta0,  S/beta+,  SC 44  40  1  2.3
Gender 0.044
Female 52  47.3  5  9.6
Male 58  52.7  14  24.1
Alpha thalassemiaa 0.164
Present 34  32.1  3  8.8
Absent 72  67.9  14  19.4
Haplotypesa 0.116
CAR 91  89.2  17  18.7
Non-CAR  11  10.8  0  0.00
Fetal hemoglobin  0.293
(≥10%) 46  41.8  10  21.7
(<10%) 64  58.2  9  14.1
Family incomeb 0.432
Up to  2  MW  80  74  12  15
>2 MW  28  26  6  21.4
Maternal  level  of  schoolingb 0.329
Incomplete elementary  school  41  38  5  12.2
Complete  elementary  school  67  62  13  19.4
Paternal  level  of  schoolingb 0.491
Incomplete elementary  school 56  51.8  8  14.3
Complete  elementary  school 52  48.2 10  19.2
SCA, sickle cell anemia; CAR, Central African Republic; MW, minimum wage in Brazil.
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ia 106 tests were performed for -thal and 102 for haplotype ide
b 108 socioeconomic questionnaires were applied.
Flanangan  et  al.  demonstrated  a  signiﬁcant  associ-
tion  between  -thal  and  the  genetic  polymorphisms
single-nucleotide  polymorphisms  [SNPS])  ADCY9  rs2238432
n  stroke  reduction;  three  SNPs  (ANXA2  rs11853426,  TEK
s489347,  and  TGFBR3  rs284875)  were  signiﬁcantly  asso-
iated  with  an  increased  risk  of  stroke;  the  deﬁciency
f  glucose-6-phosphate  dehydrogenase  and  the  haplotypes
ere  not  related  to  increased  or  reduced  risk.  Belisário  et  al.
escribed  an  increase  in  the  risk  of  stroke  in  patients  that
xpress  TNF-alpha  (−308G>A),  but  did  not  show  a  signiﬁcant
ssociation  with  the  expression  of  VCAM-1  polymorphism
c.1238G>C),  and  associated  -thal  with  reduced  risk  of
troke.  These  results  suggest  that  the  association  between
troke  and  polymorphisms  remains  controversial.1,2,9,15,20--22
he  present  study  assessed  the  associations  between  stroke,
-thal,  and  haplotypes,  and  no  signiﬁcant  results  were
ound,  which  could  be  due  to  the  small  size  of  the  study
opulation.  In  this  study  there  were  no  reports  of  stroke
mong  children  with  SCD  type  SC  and  S/beta+ thalassemia,
ata  consistent  with  the  Cooperative  Study  Group  in  SCD.1It  is  worth  mentioning  that  the  population  of  this  study
onsisted  of  all  children  diagnosed  with  SCA  (n  =  66)  in
he  area  covered  by  the  health  institution  that  encom-
asses  a  population  of  730,264  inhabitants  [IBGE  (Brazilian
t
A
h
wation.
nstitute  of  Geography  and  Statistics)  Census  2010]  Sarnaik
nd  Ballas11 emphasized  the  importance  of  multicenter  stud-
es  with  large  numbers  of  patients  with  and  without  stroke,
o  determine  the  implication  of  genetic  marker  studies  on
he  morbidity  and  mortality  in  SCD.
The  incidence  of  SCA  in  this  study  was  one  case  for  every
857  live  births  and  one  case  of  SCD  type  SC  for  every  5128.
ccording  to  the  Ministry  of  Health,  the  incidence  of  SCD
etected  in  the  PETN  was:  Bahia,  1:  650;  Rio  de  Janeiro,  1:
300;  Pernambuco,  Maranhão,  Minas  Gerais,  and  Goiás:  1:
400;  Espírito  Santo,  1:  1800;  Sao  Paulo,  1:  4000;  Rio  Grande
o  Sul,  1:  11,000;  Santa  Catarina  and  Parana,  1:  13,500.19
Bezerra  et  al.5 genetically  characterized  a cohort  of  74
hildren  with  SCA  in  Pernambuco  and  showed  that  approx-
mately  65%  of  patients  had  the  CAR/CAR  haplotype,  a
requency  greater  than  that  found  in  other  states  in  north-
astern  Brazil  and  higher  than  the  53%  found  in  our  study.
This  study  did  not  identify  the  Benin/Benin  haplotype
mong  children  with  SCA,  similar  results  to  those  found
n  Rio  de  Janeiro.13,14 Previous  reports  showed  that  haplo-
ypes  are  associated  with  an  increased  risk  of  stroke.2,11,23,27
ccording  to  the  present  data,  the  presence  of  the  CAR
aplotype  (present  in  89.2%  of  cases)  was  not  associated
ith  the  development  of  stroke.  These  results  are  similar  to
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Table  3  Frequencies  of  factors  associated  with  stroke  in  individuals  with  sickle  cell  anemia.
Factors  Absolute  frequency  and  percentage
of categories  of  factors
Absolute  frequency  and
percentage  of  presence  of  stroke
p-Value
n  %  n  %
Type  of  hemoglobinopathy
SCD  66  100  18  27.3
Gender 0.042
Female 28  42.4  4  14.3
Male 38  57.6  14  36.8
Alpha thalassemiaa 0.196
Present 20  30.3  3  15
Absent 43  65.2  13  30.2
Haplotypesa 0.543
CAR 59  89.4  16  27.1
Non-CAR 1  1.5  0  0.00
Fetal Hemoglobin
(≥10%)  41  62.1  9  22
(<10%) 25  37.9  9  36
Family incomeb 0.593
Up to  2  MW  49  74.2  12  24.5
>2 MW  16  24.2  5  31.3
Maternal level  of  schoolingb 0.854
Incomplete  elementary  school  18  27.3  5  27.8
Complete elementary  school  47  71.2  12  25.5
Paternal level  of  schoolingb 0.591
Incomplete  elementary  school 27  40.9  8  29.6
Complete elementary  school 38  57.6  9  23.7
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a 63 tests were performed for -thal and 60 for haplotype ident
b 65 socioeconomic questionnaires were applied.
those  of  Flanangan  et  al.22 and  Loghetto,24 who  found  no  sig-
niﬁcant  correlation  between  the  haplotypes  and  stroke.  In
2011,  Domingos  et  al.12 studied  a  population  in  Pernambuco
different  from  the  one  studied  by  Bezerra  et  al.,5 with  261
patients,  of  whom  67  had  stroke,  and  found  no  association
between  haplotypes  and  stroke.
In  Brazil,  the  type  of  deletion  that  leads  to  -thal  is
almost  exclusively  the (−3.7) type.9 The  incidence  of  -thal
found  in  individuals  with  SCA  in  this  study  was  30.3%,  consid-
ering  the  deletion  of  one  and  two  genes.  These  data  were
similar  to  those  found  in  Salvador  (28.2%)  and  higher  than
those  found  by  Figueiredo,  which  was  18.8%  in  São  Paulo.4,9
Several  studies12,15,22 have  shown  the  preventive  effect
of  -thalassemia  on  the  development  of  stroke  in  chil-
dren  with  SCA.  Belisario  et  al.9 and  Hsu  et  al.10 reported
that  the  frequency  of  -thal  was  signiﬁcantly  higher  in
patients  with  SCA  with  no  alterations  at  the  TCD,  suggesting
molecular  protection  from  the  development  of  stroke.  Dif-
ferently  from  the  present  analysis,  these  markers  showed
no  signiﬁcant  association  with  stroke  risk,  results  also  found
by  Silva  Filho13 and  Sommet  et  al.6 These  ﬁndings  sug-
gest  a  possible  genetic  heterogeneity  among  populations,
which  may  explain  the  differences  among  the  results  of
the  studies.  The  manual  of  SCD  conduct  and  management,
‘‘Evidence-Based  Management  of  Sickle  Cell  Disease’’  of
t
t
i
mwage in Brazil.
ion.
he  National  Institutes  of  Health  (NIH),  published  in  2014,
oes  not  advise  genetic  screening  for  the  prevention  of
troke.25
Socioeconomic  factors,  such  as  family  income  and  the
aregiver’s  level  of  schooling,  are  described  as  social  vul-
erability  risks  and  determinants  of  major  health  problems
f  the  population  with  SCD.3,26--29 Such  associations  were
ot  observed  in  this  study.  In  Minas  Gerais,  the  implemen-
ation  of  a  comprehensive  care  policy  for  patients  with
CD  provides  continuous  and  multidisciplinary  care,  which
ay  have  had  a  positive  impact  by  reducing  the  socioeco-
omic  effects  on  the  management  of  the  disease  (Center
or  Education  and  Support  for  Hemoglobinopathies  --  MG  --
ww.cehmob.org.br).
The  incidence  of  stroke  was  signiﬁcantly  higher  in  chil-
ren  with  SCA  and  males,  data  already  identiﬁed  in  the
nternational  Pediatric  Stroke  Group.30 The  analysis  of  the
oexistence  of  -thal  and  haplotypes  in  this  study  showed
o  correlation  in  the  genesis  or  prevention  of  stroke.  The
eterogenicity  between  previously  assessed  populations,
on-reproducibility  between  studies,  and  the  need  to  iden-
ify  factors  associated  with  stroke  in  patients  with  SCA  show
he  importance  of  new  studies,  considering  this  pathology
s  the  most  prevalent  monogenic  disease  in  the  world  and  a
atter  of  public  health  concern.
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unding
ll  laboratory  material  used  in  the  development  of  the
tudy,  such  as  DNA  extraction  kits,  PCR  reagents,  restric-
ion  enzymes,  tubes,  and  pipette  tips  were  purchased  with
he  budget  provided  by  FAPEMIG  through  PPSUS/FAPEMIG
CDS-APQ-01431-10)  and  the  research  laboratory  sector  of
undac¸ão  Hemominas.  The  research  fellowships  for  the
ndergraduate  students  involved  in  the  study  were  provided
y  FAPEMIG.
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